Major test of 1st potential Lyme disease vaccine in 20 years begins in U.S., Europe

Pfizer and French biotech company Valneva are seeking volunteers to test their new vaccine against Lyme disease, which could protect both adults and kids as young as five from the tick-borne illness.

Related Keywords

Germany ,Altoona ,Pennsylvania ,United States ,Netherlands ,Williamsburg ,Sweden ,Finland ,Duncansville ,Poland ,Canada ,France ,Canadian ,French ,Gary Wormser ,Robert Terwilliger ,Annaliesa Anderson ,Alan Kivitz ,Janae Roland ,Garym Baranec ,Yale University ,Us Centers For Disease ,York Medical College ,Associated Press ,Pfizer ,University Of Massachusetts ,Altoona Center ,Health Canada ,Clinical Research In Duncansville ,Disease Control ,New York Medical College ,Clinical Research ,